• IMA sites
  • IMAJ services
  • IMA journals
  • Follow us
  • Alternate Text Alternate Text
עמוד בית
Tue, 17.11.26

Search results


November 2026
Yarden Riskin MSc, Arieh Riskin MD PhD

Metacognition, which is the capacity to monitor, evaluate, and regulate one’s own cognitive processes, is an important determinant of clinical decision quality. Clinicians who fail to monitor their reasoning are more susceptible to the systematic cognitive biases that contribute to many diagnostic errors. In this narrative review, we integrated theoretical models of metacognition, presented research on intuitive and analytical clinical reasoning, showed empirical studies of cognitive bias in medicine, and described educational interventions targeting metacognitive skills. The review is built on the monitoring–control framework in which monitoring is what clinicians notice about their own reasoning and control is what they do in response. Two monitoring signals are most directly relevant to diagnosis: confidence, which is often poorly calibrated to actual accuracy, and the feeling of rightness, which determines whether an initial diagnosis is reconsidered. Using clinical examples of anchoring, premature closure, availability bias, overconfidence, and confirmation bias, we specified what the clinician needed to monitor and the control action for each bias.

We described a diagnostic time-out, an active search for disconfirming evidence, a discriminating test, or consultation, that monitoring should have triggered. Structured reflection and calibration feedback have shown benefit, whereas bias education alone has shown limited effect on diagnostic accuracy. Metacognitive capacity is a modifiable, teachable competency. Its development is a patient safety imperative, and medical education programs should incorporate explicit metacognitive training, which are linked to concrete clinical cues and actions, as a core component of clinical reasoning curricula.

Maxim Glebov MD, Alex Mintz PhD

Generative artificial intelligence (GenAI), particularly large language models, is increasingly used in medicine to support diagnosis, risk prediction, treatment planning, workflow optimization, documentation, and clinical decision-making. Its ability to process large amounts of data and identify complex patterns may greatly improve patient care and assist clinicians in increasingly data-rich healthcare environments. However, GenAI systems are not inherently neutral, and their use in medicine creates a broad spectrum of clinical risks.

These risks include biased or unrepresentative data, poor generalizability, inconsistent recommendations, inaccurate labels, inappropriate outcome proxies, opacity, automation bias, erosion of clinical expertise, hallucinations, fabricated evidence, cybersecurity vulnerabilities, privacy concerns, and unclear accountability. In clinical settings, these risks may lead to misdiagnosis, over- or undertreatment, unequal allocation of resources, propagation of false evidence, inappropriate reliance on automated outputs, and loss of trust. In this review, we discuss the major clinical risks and mechanisms of harm associated with GenAI in medicine, provide clinical examples, and suggest strategies to reduce harm. GenAI should be viewed as a powerful clinical tool, but not as a replacement for human judgment, professional accountability, or compassionate medical care.

Ayala Gover MD, Arieh Riskin MD PhD

Medical decision-making has historically been modeled as a rational, cognitive process. Substantial evidence now challenges this view, demonstrating that emotions, both those arising from the clinical encounter itself and those carried over from unrelated contexts, substantially influence clinical judgment, risk assessment, and treatment choices.

In this narrative review of foundational psychological theory and empirical studies in emotion science and clinical medicine, with emphasis on work published since 2000 and on recent systematic reviews, we examine how emotions affect medical decision-making, the psychological mechanisms involved as described by the appraisal tendency framework, and the evidence-based strategies for emotion regulation that can improve clinical reasoning. Emotions influence clinical decisions through multiple pathways: integral emotions, arising from the decision itself, directly shape risk perception and treatment intensity, while incidental emotions, carried over from unrelated events, systematically bias judgment.

Legal Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal or medical advice on any matter.
The IMA is not responsible for and expressly disclaims liability for damages of any kind arising from the use of or reliance on information contained within the site.
© All rights to information on this site are reserved and are the property of the Israeli Medical Association. Privacy policy

2 Twin Towers, 35 Jabotinsky, POB 4292, Ramat Gan 5251108 Israel